Literature DB >> 3146882

Growth and final height in classical and nonclassical 21-hydroxylase deficiency.

M I New, J M Gertner, P W Speiser, P del Balzo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3146882

Source DB:  PubMed          Journal:  Acta Paediatr Jpn        ISSN： 0374-5600


× No keyword cloud information.
  13 in total

1.  Growth hormone response to physical exercise in growing patients with classic congenital adrenal hyperplasia.

Authors:  C Bizzarri; G Ubertini; F Crea; D Colabianchi; S Loche; L Ravà; M Cappa
Journal:  J Endocrinol Invest       Date:  2009-06-24       Impact factor: 4.256

2.  Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia.

Authors:  I N Silva; C E Kater; C F Cunha; M B Viana
Journal:  Arch Dis Child       Date:  1997-09       Impact factor: 3.791

Review 3.  Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): an update.

Authors:  Christine M Trapp; Sharon E Oberfield
Journal:  Steroids       Date:  2011-12-13       Impact factor: 2.668

4.  Hypoglycemia during acute illness in children with classic congenital adrenal hyperplasia.

Authors:  Margaret F Keil; Charlotte Bosmans; Carol Van Ryzin; Deborah P Merke
Journal:  J Pediatr Nurs       Date:  2008-11-04       Impact factor: 2.145

5.  Final adult height in children with congenital adrenal hyperplasia treated with growth hormone.

Authors:  Karen Lin-Su; Madeleine D Harbison; Oksana Lekarev; Maria G Vogiatzi; Maria I New
Journal:  J Clin Endocrinol Metab       Date:  2011-03-30       Impact factor: 5.958

6.  Success of glucocorticoid replacement therapy on fertility in two adult males with 21-CAH homozygote classic form.

Authors:  R Valentino; S Savastano; A P Tommaselli; M T Scarpitta; M Dorato; M Gigante; E Calvanese; M Carlino; G Lombardi
Journal:  J Endocrinol Invest       Date:  1997-12       Impact factor: 4.256

7.  Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients.

Authors:  H J Van der Kamp; B J Otten; N Buitenweg; S M P F De Muinck Keizer-Schrama; W Oostdijk; M Jansen; H A Delemarre-de Waal; T Vulsma; J M Wit
Journal:  Arch Dis Child       Date:  2002-08       Impact factor: 3.791

8.  Management of 21-hydroxylase deficiency congenital adrenal hyperplasia: A survey of Canadian paediatric endocrinologists.

Authors:  Robert Stein; Diane Wherrett; Denis Daneman
Journal:  Paediatr Child Health       Date:  2005-07       Impact factor: 2.253

Review 9.  Congenital adrenal hyperplasia: transition from chil dhood to adulthood.

Authors:  P W Speiser
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 5.467

10.  A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia.

Authors:  Somya Verma; Carol Vanryzin; Ninet Sinaii; Mimi S Kim; Lynnette K Nieman; Shayna Ravindran; Karim A Calis; Wiebke Arlt; Richard J Ross; Deborah P Merke
Journal:  Clin Endocrinol (Oxf)       Date:  2009-05-25       Impact factor: 3.478
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.